Home › Database search ›

HSNO application register

The application register is a record of HSNO applications made to us and includes documents related to these applications.

You can search this database by application or approval number.

Please note: The decision documents on this register may not be the current legal approval document for substances included in the application. Substance approvals were reissued on 30 April 2021 to apply the GHS classification system.

Copy and paste the following links to your browser to help you find the correct information:

https://www.epa.govt.nz/assets/Uploads/Documents/Hazardous-Substances/GHS2/Individual-Hazardous-Substance-Approvals.pdf

https://www.epa.govt.nz/assets/Uploads/Documents/Hazardous-Substances/GHS2/GHS_Classifications_and_Fates_30_April_2021.xlsx

You can also search the Approved Hazardous Substances with Controls database and the CCID for information.

Showing 5001 - 5010 of 5415 results for " "

Sort by: Relevance | Date

  • GMD00105

    Decision notified date: 26/07/2000

    To study the mechanisms of cell adhesion and chronic inflammatory processes

  • GMD00099

    Decision notified date: 26/07/2000

    To develop in vitro systems to investigate the interaction of Hepatitis B virus with hepatocytes

  • GMD00104

    Decision notified date: 26/07/2000

    To study the transcriptional regulation of adhesion molecules beta 7 and MadCAM

  • GMD00117

    Decision notified date: 26/07/2000

    The purpose of this application is to use Escherichia coli expression systems to produce specific streptococcal adhesin polypeptides for research purposes

  • GMD00106

    Decision notified date: 26/07/2000

    To investigate the role of protein and peptide aggregation in neurodenegerative disorders such as Huntington's and Alzheimers disease

  • GMD00109

    Decision notified date: 26/07/2000

    To understand the regulation of photosynthesis or flowering in Arabidopsis

  • GMD00120

    Decision notified date: 26/07/2000

    The development of these genetically modified organisms is central to medical research aimed at understanding the genetic basis of the development and function …

  • GMD00115

    Decision notified date: 26/07/2000

    To construct strains of E coli for research into vaccines

  • GMD00101

    Decision notified date: 26/07/2000

    To understand transporter proteins in prokaryotes and eukaryotes and develop novel therapies for Helicobacter infection

  • GMD00119

    Decision notified date: 26/07/2000

    The application is made to seek approval to clone and express H. pyloriLpp20 with the sole purpose of using the recombinant protein in the development of an eff…

Print